Manufacturer record
Nandani Medical Laboratories Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
12 batches manufactured by Nandani Medical Laboratories Pvt. Ltd (Madhya Pradesh) were declared Not of Standard Quality between November 2022 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: HSV22406, Heparin Sodium Injection IP 5000 IU/ml (exp Oct 2026). CDL, Kolkata (CDSCO lab) found it not of standard quality: The sample does not conform to I.P. with respect to the Assay of Heparin (Anti-factor IIa activity). Listed in the May 2026 alert.
Records by type
12 records linked to Nandani Medical Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Heparin Sodium Injection IP 5000 IU/ml | Batch HSV22406Mfg Nov 2024 · Exp Oct 2026 | The sample does not conform to I.P. with respect to the Assay of Heparin (Anti-factor IIa activity)Assay | CDL, KolkataCDSCO lab | May 2026 |
| Heparin Sodium Injection IP 5000 IU/ml | Batch BSV22501Mfg Feb 2025 · Exp Jan 2027 | The sample does not conform to I.P. with respect to Assay of Heparin (Anti-factor IIa activity)Assay | CDL, KolkataCDSCO lab | May 2026 |
| Cefotaxime Sodium Injection IP 1000 mg | Batch CT42414Mfg Jul 2024 · Exp Jun 2026 | The sample does not conform to I.P. with respect to test for Clarity of solution and Particulate matter.Particulate matter | CDL, KolkataCDSCO lab | Jan 2026 |
| Ondansetron Injection IP 2 mg/ml | Batch ONA12515Mfg Jan 2025 · Exp Dec 2026 | Particulate matterParticulate matter | CDL, KolkataCDSCO lab | May 2025 |
| Dobutamine Hydrochloride Injection IP 5 ml | Batch DBA12404Mfg Aug 2024 · Exp Jul 2026 | Particulate matter and DescriptionDescription | CDL, KolkataCDSCO lab | May 2025 |
| BUPIVACAINE HYDROCHLORI DE INJECTION IP 0.5% | Batch BCV22315Mfg Dec 2023 · Exp Nov 2025 | Particulate mattter and DescriptionDescription | CDL KolkataCDSCO lab | Dec 2024 |
| Iron Sucrose Injection USP 5 ml | Batch IRA12320Mfg Aug 2023 · Exp Jul 2025 | Specific Gravity, Particulate matter, Assay of Sucrose & Assay of Ferric Hydroxide with sucrose calculated as elemental IronAssay | CDL KolkataCDSCO lab | Oct 2024 |
| Atropine Sulphate Injection IP 2 ml | Batch ATA12407Mfg Mar 2024 · Exp Feb 2026 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Aug 2024 |
| Frusemide Injection IP 2 ml (FRUSEMIDE) | Batch FRA12347Mfg Dec 2023 · Exp Nov 2025 | pHpH | CDL KolkataCDSCO lab | Jun 2024 |
| Dexamethasone SodiumPhosphate Injection I.P | Batch DSA123 13Mfg Jul 2023 · Exp Jun 2025 | The sample does not conforms to IP with respect to Assay/ content of Dexamethasone PhosphateAssay | CDL KolkataCDSCO lab | May 2024 |
| Gentamicin (Gentamicin Injection I.P.) ? 2 ml | Batch GM22242Mfg Jul 2022 · Exp Jun 2024 | Description and Particulate MatterDescription | CDL KolkataCDSCO lab | May 2023 |
| Frusemide Injection I.P. 2ml | Batch FR12223Mfg Jul 2022 · Exp Jun 2024 | SterilitySterility | CDL KolkataCDSCO lab | Nov 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.